Medicines for Europe

Medicines for Europe is a leading organization representing the generic, biosimilar, and value-added medicines industries throughout Europe. With a strong vision to ensure sustainable access to high-quality medicines, Medicines for Europe focuses on five essential pillars: patients, quality, value, sustainability, and partnership. The organization's dedication supports the development and distribution of vital pharmaceutical products.

Medicines for Europe members are significant contributors to the European economy, directly employing 190,000 people across more than 400 manufacturing and 126 R&D sites. These companies invest up to 17% of their turnover in research and development, highlighting their commitment to innovation and advancement in the pharmaceutical sector. Medicines for Europe is headquartered at Rue d'Arlon, 50, Brussels, 1000, BE.

Medicines for Europe plays a crucial role in enhancing access to medicines and driving improved health outcomes across Europe. By providing high-quality, effective generic medicines, innovating in biosimilar medicines, and introducing value-added medicines, they contribute to more efficient and safer healthcare systems. We invite the management of Medicines for Europe to create a customized and exclusive company showcase and product listing on our platform to further amplify their impact and reach.